[ Numaferm raises undisclosed amount in Seed Funding ]
Numaferm has raised an undisclosed amount in Seed Funding.
Founded in 2017, Numaferm is a biochemical company that develops a technology for peptide production in escherichia coli bacterium for the pharmaceutical industry.
The company will use the new financing for the further technological development and an accelerated market entry.
|Founder / CEO||Dr. Christian , Schwarz|
|Investors||European Investment Fund|